Augmentation of Antibody Synthesis in Vitro by Thymosin Fraction 5

The Influence of Age
  • William B. Ershler
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


Previously, techniques available for the measurement of specific antibody synthesized in vitro have been complex and have usually required the addition of a nonspecific mitogen, such as pokeweed mitogen (PWM) (Fauci and Pratt, 1976; Thomson and Harris, 1977; Stevens and Saxon, 1978). We have recently described a one-step, non-mitogen-requiring assay for measuring antibody production in vitro (Ershler et al., 1982; Moore et al., 1984). One advantage of this assay is that with the addition to the culture medium of biological response modifiers such as thymosin or lymphokines, it allows the evaluation of these agents on this important immunological function. In this chapter, the effect of thymosin fraction 5 (TF5) on specific antitetanus and anti-influenza antibody production will be discussed. The in vitro effect of TF5 was found to vary with age, the most profound effect being observed in the advanced age groups (Ershler et al., 1984b). The potential therapeutic implications of these observations will also be discussed.


Antibody Production Tetanus Toxoid Biological Response Modifier Booster Immunization Pokeweed Mitogen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amman, A. J., Schiff man, G., and Austrian, R., 1980, The antibody response to pneumococcal capsular polysaccharides in aged individuals, Proc. Soc. Exp. Biol. Med. 164:312.Google Scholar
  2. Bentley, D. W., 1981, Pneumococcal vaccine in the institutionalized elderly: Review of past and present studies, Rev. Infect. Dis. 3(Suppl.):61–70.CrossRefGoogle Scholar
  3. Costanzi, J., Daniels, J., Thurman, G., Goldstein, A., and Hokanson, J., 1979, Clinical trials with thymosin, Ann. N.Y. Acad. Sci. 322:148–159.CrossRefGoogle Scholar
  4. Ershler, W. B., Moore, A. L., and Hacker, M. P., 1982, Specific in vivo and in vitro antibody response to tetanus toxoid immunization, Clin. Exp. Immunol. 49:552–558.PubMedGoogle Scholar
  5. Ershler, W. B., Moore, A. L., Hacker, M. P., Ninomiya, J., Naylor, P. B., and Goldstein, A. L., 1984b, Specific antibody synthesis in vitro. II. Age-associated thymosin enhancement of antitetanus antibody synthesis (submitted for publication).Google Scholar
  6. Ershler, W. B., Moore, A. L., and Socinski, M. A., 1984a, Specific antibody synthesis in vitro. III. Correlation of in vitro antiboly response to influenza immunization in young and old subjects (submitted for publication).Google Scholar
  7. Fauci, A. S., and Pratt, K. R., 1976, Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigen stimulation of human B lymphocytes, J. Exp. Med. 144:674–684.PubMedCrossRefGoogle Scholar
  8. Goldstein, A. L., Low, T. L. K., Thurman, G. B., Zatz, M., Hall, N. R., McClure, J. E., Hu, S.- K., and Schulof, R. S., 1982, Thymosins and other hormone-like factors of the thymus gland, in: Immunological Approaches to Cancer Therapeutics (E. Mihich, ed.), Wiley, New York.Google Scholar
  9. Lowell, G. H., Smith, L. F., Klein, D., and Zollinger, W. D., 1980, Thymosin stimulates in vitro secretion of antibacterial antibodies by human peripheral blood lymphocytes, Clin. Res. 28:A353.Google Scholar
  10. Makinodan, T., and Kay, M. M. B., 1980, Age influence on the immune system, Adv. Immunol. 29:287–330.PubMedCrossRefGoogle Scholar
  11. Moore, A. L., Ershler, W. B., and Hacker, M. P., 1984, Specific antibody synthesis in vitro. I. Technical considerations, J. Immunol. Methods (in press).Google Scholar
  12. Pahwa, R., Ikehara, S., Pahwa, S. G., and Good, R. A., 1979, Thymic function in man, Thymus 1:27–58.PubMedGoogle Scholar
  13. Price, G. B., and Makinodan, T., 1972, Immunologic deficiencies in senescence. I. Characterization of intrinsic deficiencies, J. Immunol. 180:403–412.Google Scholar
  14. Smith, A. M., 1976, The effects of age on the immune response to type III pneumosaccharide (SIII) and bacterial lipopolysaccharide (LPS) in Balb/c, SJL/J and C3H mice, J. Immunol. 116:469–474.PubMedGoogle Scholar
  15. Stevens, R. H., and Saxon, A., 1978, Immunoregulation in humans: Control of antitetanus toxoid antibody production after booster immunization, J. Clin. Invest. 62:1154–1160.PubMedCrossRefGoogle Scholar
  16. Thomson, P. D., and Harris, N. S., 1977, Detection of plaque-forming cells in the peripheral blood of actively immunized humans, J. Immunol. 118:1480–1482.PubMedGoogle Scholar
  17. Weksler, M. E., and Huuteroth, H., 1974, Impaired lymphocyte function in aged humans, J. Clin. Invest. 53:99–104.PubMedCrossRefGoogle Scholar
  18. Willcox, H. N. A., 1975, Thymus dependence of the antibody response to tetanus toxoid in mice, Clin. Exp. Immunol. 22:341–347.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • William B. Ershler
    • 1
  1. 1.Department of MedicineUniversity of VermontBurlingtonUSA

Personalised recommendations